0 CHECKOUT

Zalicus Inc. (formerly CombinatoRx, Incorporated) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • ID: 2347185
  • March 2013
  • 52 pages
  • MarketLine

Project Synopsis:

MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage.

Project Description:

MarketLines' Zalicus Inc. (formerly CombinatoRx, Incorporated) Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Zalicus Inc. (formerly CombinatoRx, Incorporated) since January 2007.

Scope:

– Provides intelligence on Zalicus Inc. (formerly CombinatoRx, Incorporated)'s M&A, strategic partnerships and alliances, capital raising and private equity transactions.
– Detailed reports of various financial transactions undertaken by Zalicus Inc. (formerly CombinatoRx, Incorporated) and its subsidiaries since 2007.
– Information about key financial and legal advisors for Zalicus Inc. (formerly CombinatoRx, READ MORE >

Note: Product cover images may vary from those shown

COMPANY OVERVIEW AND KEY FACTS
MERGERS & ACQUISITIONS
--Mergers and Acquisitions – Overview
--Mergers and Acquisitions – Deal reports
PARTNERSHIP
--Partnership – Overview
--Partnership – Deal reports
--Capital Raising – Deal reports

APPENDIX
--About MarketLine Financial Deals Database
--Deal Definition and Methodology
--About MarketLine
--MarketLine Professional Services Knowledge Center

LIST OF TABLES

--Zalicus Inc. (formerly CombinatoRx activity by deal type – volume (trailing twelve months (TTM))
--Zalicus Inc. (formerly CombinatoRx M&A activity by geography (2008 -YTD2012)
--Zalicus Inc. (formerly CombinatoRx activity by deal type – volume (2008 -YTD2012)
--Zalicus Inc. (formerly CombinatoRx M&A average deal size – value ($m) (2008 -YTD2012)
--Zalicus Inc. (formerly CombinatoRx legal advisor ranking by value ($m)
--Zalicus Inc. (formerly CombinatoRx financial advisor ranking by value ($m)
--Top Deals(2008 -YTD2012)
--Zalicus Inc. (formerly CombinatoRx targets and partners (2008 -YTD2012)
--Zalicus Inc. (formerly CombinatoRx M&A volume and value trend (2008-YTD2012)
--Zalicus Inc. (formerly CombinatoRx M&A activity by geography (2008-YTD2012)
--Zalicus Inc. (formerly CombinatoRx partnership volume and value trend (2008-YTD2012)
--Zalicus Inc. (formerly CombinatoRx partnership trend by key deal type (2008-YTD2012)

LIST OF FIGURES

--Zalicus Inc. (formerly CombinatoRx activity by deal type - volume (trailing twelve months (TTM))
--Zalicus Inc. (formerly CombinatoRx M&A activity by geography (2008-YTD2012)
--Zalicus Inc. (formerly CombinatoRx activity by deal type - volume (2008-YTD2012)
--Zalicus Inc. (formerly CombinatoRx M&A average deal size - value ($m)
--Zalicus Inc. (formerly CombinatoRx M&A volume and value trend (2008-YTD2012)
--Zalicus Inc. (formerly CombinatoRx M&A activity by geography (2008-YTD2012)
--Zalicus Inc. (formerly CombinatoRx partnership volume and value trend (2008-YTD2012)
--Zalicus Inc. (formerly CombinatoRx partnership trend by key deal type (2008-YTD2012)

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.